Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17
Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between six and 17.
